Physician profile
Maria S Cortina
NPI 1376733774
$88,030.13
in general payments reported to CMS, 2019-2025
10 companies · $56K in 2025
The $56K reported for 2025 was more than what 98% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $768 · 2020: $3,498 · 2021: $5,789 · 2022: $7,875 · 2023: $9,529 · 2024: $4,870 · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $68K · Travel and Lodging: $1,567 · Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $67,800.00 |
| Travel and Lodging | $1,566.83 |
| Food and Beverage | $734.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $86,216.02 | 2019-2025 | Product In Development |
| Axogen | $1,500.00 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $115.34 | 2023 | Iolmaster 700 |
| Bausch & Lomb Americas INC. | $40.48 | 2023-2024 | Miebo, Xiidra |
| Alcon Vision LLC | $38.03 | 2019-2024 | Clareon |
| Biotissue Holdings INC. | $37.91 | 2024 | |
| Rayner Intraocular Lenses Limited | $30.85 | 2024 | Omidria |
| Johnson & Johnson Surgical Vision, INC. | $28.87 | 2023 | Tecnis Iol |
| Sun Pharmaceutical Industries INC. | $22.63 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Cortina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.